Initial information regarding this unsolicited case from the United States was received on 01-Oct-2014 from the 
physician.
This case involves a female patient of unknown age, whose result came back positive for the JC virus, 91 days 
after starting therapy with teriflunomide (Aubagio).
Past drug included albumin human/glucose/interferon beta (Betaseron). No medical history, concurrent conditions 
or concomitant medications were reported.
On 18-Jun-2014, the patient started therapy with teriflunomide (strength, route, form, dose, frequency, lot/batch 
number and expiry date not provided) for multiple sclerosis.
On 17-Sep-2014, 91 days after starting therapy with teriflunomide, patient's result came back positive for the JC 
Print Time: 26-MAY-2016 01:56 PM If a field is blank, there is no data for that field Page 220 of 675
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
virus. This was her first test for JC virus.
Action taken: Drug withdrawn NOS
Corrective treatment: Not reported
Outcome: unknown
Reporter causality: Not reported
No further information available.